Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
News Briefing channel feed
Vera redraws the terms of up to $500M credit facility; Trevi aims to raise $100M
Last month
Sanofi pays out two STAT6 milestones; Theravance sells more Trelegy royalties
Last month
Roche’s 96-week data for multiple sclerosis drug; ZymeWorks claims $20M milestone
Last month
Taysha’s pivotal trial plans; Keros to stop work on PAH drug, lay off 45% of staff
Last month
Veru’s obesity drug roughly as safe as Wegovy; Keros’ board fight
Last month
ITM reveals up to $262M debt financing; Caris Life Sciences to go public
Last month
GLP-1s may cut cancer risk; Gyre’s stock falls after hep B data and offering
Last month
Moderna pulls application for Covid-flu shot; Another IPO in Hong Kong
Last month
SV Health’s $269M dementia fund; Schrödinger lays off 7% of staff
Last month
Ionis details late-stage data for heart drug; Armata’s promising staph infection therapy
Last month
FDA lifts hold on Scynexis trial; Incyte’s Zynyz notches another FDA approval
Last month
Enliven stops work on solid tumor drug; Pulmatrix to divest assets
Last month
SK, Carlyle bolster bluebird bio bid; Therini Bio raises $39M
Last month
Axsome's $570M loan with Blackstone; Altimmune makes its own credit deal
Last month
FDA clears in vivo blood stem cell editing trial; Abeona's $155M PRV sale
Last month
AstraZeneca reports Phase 3 win for Imfinzi; Roche to build new manufacturing site in China
2 months ago
ALX Oncology won’t seek approval for CD47 drug in gastric cancer; Korro Bio’s layoffs
2 months ago
European regulators to review Valneva shot; Jazz's stock dips on subpar first-quarter revenue
2 months ago
Lilly to pay up to $415M in ALS deal; Actuate’s mid-stage pancreatic cancer data
2 months ago
Unity lays off 'all' workers; Novo to get FDA decision on oral Wegovy this year
2 months ago
Kura gets $45M milestone payment from Kyowa Kirin; Pliant’s restructuring
2 months ago
Arvinas ends plans for two Phase 3 breast cancer trials; Phathom makes cuts
2 months ago
Immunic’s stock falls on multiple sclerosis data; Entrada’s layoffs
2 months ago
AbbVie’s Rinvoq is approved in giant cell arteritis; Relmada shares bladder cancer data
2 months ago
First page
Previous page
1
2
3
4
5
Next page
Last page